| Literature DB >> 29799496 |
Yong-Sheng Yang1, Li-Jun Liu2, Hai-Yan Ju3, Xiu-Ying Liu4, Yu-Guang Li5, Shi-Ping Yan6.
Abstract
A novel 36-metallacrown-6 complex [CuL(N(CN)₂)(PF₆)]₆∙0.5H₂O 1 was achieved using a tridendate ligand, 1,4,7-triisopropyl-1,4,7-triazacyclononane (L), and a flexible ligand, dicyanamide in MeOH. The μ1,5 bridging models of the dicyanamide ligand linked the macrocycle to form in a specific size with the chair conformation. The anion was important to form this 36-metallacrown-6 complex, as change was obtained with the larger anion BPh₄-, binuclear copper compound 2. The magnetic property indicates that slightly ferromagnetic interactions resulted from a superexchange mechanism. DNA binding properties were also studied. UV and fluorescence spectra showed that complex 1 could bind with DNA.Entities:
Keywords: 1,4,7-triazacyclononane; DNA binding properties; dicyanamide; metallacrown
Mesh:
Substances:
Year: 2018 PMID: 29799496 PMCID: PMC6099552 DOI: 10.3390/molecules23061269
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Crystal data and structure refinement for 1 and 2.
| Compound | 1 | 2 |
|---|---|---|
| Empirical formula | C17H33.17CuF6N6O0.08P | C82H106Ni2B2N12 |
| Formula weight | 531.51 | 1398.83 |
| Temperature | 294(2) K | 293(2) K |
| Wavelength | 0.71073 Å | 0.71073 Å |
| Crystal system, space group | Rhombohedral, | Triclinic, |
| Unit cell dimensions | ||
| Volume | 10964(2) Å−3 | 1890.2(6) Å−3 |
| 18, 1.449 Mg m−3 | 1, 1.229 Mg m−3 | |
| Absorption coefficient | 1.024 mm−1 | 0.550 mm−1 |
| 4965 | 748 | |
| Crystal size | 0.26 × 0.20 × 0.16 mm3 | 0.24 × 0.20 × 0.14 mm3 |
| 1.43–25.02° | 1.99–26.40° | |
| Limiting indices | −33 ≤ | −12 ≤ |
| Reflections collected/unique | 18,801/4320 [ | 10,744/7607 [ |
| Max. and min. transmission | 1.000000 and 0.712842 | 1.000000 and 0.818876 |
| Refinement method | Full-matrix least-squares on | Full-matrix least-squares on |
| Data/restraints/parameters | 4320/54/287 | 7607/0/448 |
| Goodness-of-fit on | 1.066 | 1.006 |
| Final | ||
| Largest diff. peak and hole | 0.558 and −0.362 e Å−3 | 0.326 and −0.290 e Å−3 |
Selected bond lengths (Å) and angles (°) for 1 and 2.
|
| |||
| Cu(1)-N(4) | 1.992(3) | Cu(1)-N(2) | 2.077(3) |
| Cu(1)-N(6) | 2.001(4) | Cu(1)-N(3) | 2.201(3) |
| Cu(1)-N(1) | 2.070(3) | ||
| N(4)-Cu(1)-N(6) | 86.05(14) | N(1)-Cu(1)-N(2) | 85.62(12) |
| N(4)-Cu(1)-N(1) | 95.30(13) | N(4)-Cu(1)-N(3) | 118.49(15) |
| N(6)-Cu(1)-N(1) | 178.58(14) | N(6)-Cu(1)-N(3) | 93.39(16) |
| N(4)-Cu(1)-N(2) | 154.96(15) | N(1)-Cu(1)-N(3) | 85.58(14) |
| N(6)-Cu(1)-N(2) | 93.35(14) | N(2)-Cu(1)-N(3) | 86.55(13) |
|
| |||
| Ni(1)-N(4) | 2.022(2) | Ni(1)-N(1) | 2.065(2) |
| Ni(1)-N(6) | 2.086(2) | Ni(1)-N(3) | 2.0897(19) |
| Ni(1)-N(2) | 2.0992(18) | ||
| N(4)-Ni(1)-N(1) | 117.56(9) | N(4)-Ni(1)-N(6) | 84.72(9) |
| N(1)-Ni(1)-N(6) | 93.79(9) | N(4)-Ni(1)-N(3) | 154.51(9) |
| N(1)-Ni(1)-N(3) | 87.87(8) | N(6)-Ni(1)-N(3) | 95.90(8) |
| N(4)-Ni(1)-N(2) | 93.74(8) | N(1)-Ni(1)-N(2) | 87.51(7) |
| N(6)-Ni(1)-N(2) | 178.33(8) | N(3)-Ni(1)-N(2) | 85.19(7) |
Symmetry operation is P–1 for 1 and R–3 for 2.
Figure 1Diagram showing the perspective view of complex 1 with atom labels (a) from c axis and (b) from a axis.
Figure 2Stacking diagram of 1 along the c axis showing the regular array of hexahydric rings and the PF6− anions.
Figure 3Molecular structure of the cyclic hexanuclear cation of 1 showing the cavity.
Figure 4Perspective view of the binuclear NiII complex [LNi(N(CN)2)]2(BPh4)2 2 with the atom-numbering scheme.
Figure 5XRD patterns for compound 2. (a) No adsorption of water molecules; (b) After adsorption of water molecules.
Figure 6Plots of the magnetic susceptibility of complex 1.
Figure 7(a) Absorbtion spectra of complex 1 with increasing Calf-thymus DNA (CT-DNA). The arrow shows the absorbance changes with increasing DNA concentration. The concentration of the compound was 2.0 × 10−5 M, r = [CT-DNA]/[compound] = 0–0.6. (b) Fluorescence emission spectra (excited at 305 nm) of the CT-DNA-EB (ethidium bromide) system (2.5 μM EB, 100 μM CT-DNA) in the absence and presence of 1 × 10–4 M complex 1 with increasing concentrations of complex with 0 to 4 μM (from top to bottom).